Skip to main content
. 2013 Jun 18;8(6):e66885. doi: 10.1371/journal.pone.0066885

Figure 5. Reoccurrence of GS upregulation.

Figure 5

The increase in GS immunoreactivity in the ipsilateral DG reoccurred when kindled seizures in animals treated with 10 µg MSO re-progressed to stage 4 (A, n  =  6/stage) and re-administration of MSO 10 µg injected into the ipsilateral DG on the third day after seizures re-progressed to stage 3 consistently inhibited seizure progression (B, n  =  9/group). Data are shown as mean ± S.E.M. ** P<0.01 compared with the saline group.